Effect of aortic stiffness on left ventricular long-axis systolic function in adults with Marfan syndrome

Hellenic Journal of Cardiology

Volumn 51, Issue 6, 2010, Pages 501-511

  Kiotsekoglou, Anatoli ^a   Saha, Samir K ^b   Moggridge, James C ^a   Kapetanakis, Venedictos ^c   Bijnens, Bart H ^d   Mullen, Michael J ^e   Camm, John ^a   Sutherland, George R ^a   Wilkinson, Ian B ^f   Child, Anne H ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b SUNDSVALL HOSPITAL   (Sweden)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^e ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Applanation tonometry; Augmentation index; Pulse wave velocity

Indexed keywords

FIBRILLIN 1;

ADULT; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; MARFAN SYNDROME; PARAMETER; PULSE WAVE; REGRESSION ANALYSIS; TISSUE DOPPLER IMAGING; TONOMETRY;

ADULT; AORTA; BLOOD FLOW VELOCITY; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MALE; MANOMETRY; MARFAN SYNDROME; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 78650596669     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pyeritz RE, Dietz HC. Marfan syndrome and other Microfibrillar Disorders In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. Wiley-Liss, Inc.; 2003. pp. 585-626.
2. Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005; 139C: 4-9.
3. Vitarelli A, Conde Y, Cimino E, et al. Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. Am J Cardiol. 2006; 97: 571-577.
4. Adams JN, Brooks M, Redpath TW, et al. Aortic distensibility and stiffness index measured by magnetic resonance imaging in patients with Marfan's syndrome. Br Heart J. 1995; 73: 265-269.
5. De Backer JF, Devos D, Segers P, et al. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol. 2006; 112: 353-358.
6. Rybczynski M, Koschyk DH, Aydin MA, et al. Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol. 2007; 30: 19-24.
7. Kiotsekoglou A, Sutherland GR, Kapetanakis V, et al. Primary impairment of right ventricular function in adult patients with Marfan syndrome. Heart. 2008; 94 (Supplement II): A71.
8. Alpendurada F, Wong J, Kiotsekoglou A, et al. Evidence for Marfan cardiomyopathy. Eur J Heart Fail. 2010; 12: 1085-1091.
9. Kiotsekoglou A, Alpendurada F, Wong J, Kapetanakis V, Child A, Mohiaddin R. Assessment of right ventricular function in adults with Marfan syndrome using cardiovascular magnetic resonance. EuroCMR. Athens, Greece; 2009.
10. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006; 312: 117-121.
11. Yin FC, Brin KP, Ting CT, Pyeritz RE. Arterial hemodynamic indexes in Marfan's syndrome. Circulation. 1989; 79: 854-862.
12. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27: 2588-2605.
13. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996; 62: 417-426.
14. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006; 7: 79-108.
15. Carlhäll C-J, Hatle L, Lindström L, Wranne B, Nylander E. A new method for measuring atrioventricular plane displacement with M-mode echocardiography for assessment of systolic ventricular function. Clin Physiol. 1999; 19: 197.
16. Carlhäll CJ, Lindström L, Wranne B, Nylander E. Atrioventricular plane displacement correlates closely to circulatory dimensions but not to ejection fraction in normal young subjects. Clin Physiol. 2001; 21: 621-628.
17. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002; 15: 167-184.
18. Obara S, Hayashi S, Hazama A, Murakawa M, Katsuda S. Correlation between augmentation index and pulse wave velocity in rabbits. J Hypertens. 2009; 27: 332-340.
19. Savelieva I, Aytemir K, Hnatkova K, Camm AJ, Malik M. Short-, mid-, and long-term reproducibility of the atrial signal-averaged electrocardiogram in healthy subjects: comparison with the conventional ventricular signal-averaged electrocardiogram. Pacing Clin Electrophysiol. 2000; 23: 122-127.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-845.
21. Elnoamany MF, Abdelhameed AK. Mitral annular motion as a surrogate for left ventricular function: correlation with brain natriuretic peptide levels. Eur J Echocardiogr. 2006; 7: 187-198.
22. Nikitin NP, Witte KKA, Ingle L, Clark AL, Farnsworth TA, Cleland JGF. Longitudinal myocardial dysfunction in healthy older subjects as a manifestation of cardiac ageing. Age Ageing. 2005; 34: 343-349.
23. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983; 51: 831-836.
24. Faris R, Henein MY, Coats AJS. Ventricular long axis function is predictive of outcome in patients with chronic heart failure secondary to non-ischemic dilated cardiomyopathy. Med Sci Monit. 2003; 9: CR456-465.
25. Sveälv BG, Olofsson EL, Andersson B. Ventricular long-axis function is of major importance for long-term survival in patients with heart failure. Heart. 2008; 94: 284-289.
26. Redheuil A, Yu WC, Wu CO, et al. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010; 55: 319-326.
27. Kiotsekoglou A, Bajpai A, Bijnens BH, et al. Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome. Eur J Echocardiogr. 2008; 9: 605-613.
28. London GM, Marchais SJ, Guerin AP, Pannier B. Arterial stiffness: pathophysiology and clinical impact. Clin Exp Hypertens. 2004; 26: 689-699.
29. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension. 2005; 46: 185-193.
30. Patrianakos AP, Parthenakis FI, Karakitsos D, Nyktari E, Vardas PE. Proximal aortic stiffness is related to left ventricular function and exercise capacity in patients with dilated cardiomyopathy. Eur J Echocardiogr. 2009; 10: 425-432.
31. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004; 110: 3081-3087.
32. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol. 2004; 43: 1399-1404.
33. Rosenbloom J, Abrams WR, Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J. 1993; 7: 1208-1218.
34. Williams A, Davies S, Stuart AG, Wilson DG, Fraser AG. Medical treatment of Marfan syndrome: a time for change. Heart. 2008; 94: 414-421.
35. Ramirez F, Dietz HC. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev. 2007; 17: 252-258.